Domenico Priolo

Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Progressive or Recurrent Ovarian Cancer

Gabriella Ferrandina, M. Ludovisi, Domenica Lorusso et al. · Journal of Clinical Oncology · 2008 · 300 citations · Full text

Medicine, Oncology, Pharmacology +17

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)

Stefano Cascinu, Francesco Graziano, Francesco Ferraù et al. · Annals of Oncology · 2002 · 52 citations · Full text

Medicine, Oncology, Chemotherapy +11

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

Sandro Pignata, Gabriella Ferrandina, Giovanna Scarfone et al. · BMC Cancer · 2008 · 51 citations · Full text

Medicine, Gynecology, Oncology +15

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

Sandro Pignata, Daniela Califano, D. Lorusso et al. · Annals of Oncology · 2024 · 35 citations · Full text

Medicine, Immunology, Oncology +12

Weekly gemcitabine and cisplatin chemotherapy: a well-tolerated but ineffective chemotherapeutic regimen in advanced pancreatic cancer patients. A report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD)

Stefano Cascinu, Roberto Labianca, Vincenzo Catalano et al. · Annals of Oncology · 2003 · 32 citations · Full text

Medicine, Oncology, Pharmacology +11